Taiwan FDA approves Viora’s Reaction™
Reaction™, Viora’s flagship product featuring multi-channel CORE™ technology for contouring and skin tightening treatments for the face and body, receives Taiwanese FDA certification.
April 5, 2011 – Viora is pleased to announce that we have successfully passed another regulatory evaluation. The Taiwan FDA legislative committee has approved our Reaction™ system for distribution in the region.
Despite being operational for only a year, the TFDA is a sophisticated and highly moderated regulations authority and was established on principles of precision and superior service alongside the Department of Health, Execute Yuan. After undergoing thorough and meticulous regulation examinations, Reaction™ is officially recognized as meeting the obligatory conditions in order to operate in the Taiwanese medical aesthetics industry.
Reaction™ is a pioneering system that uses multi-frequency channeling and vacuum therapy to deliver safe and effective treatments to the face and body with patented CORE™ Technology. Promed Biotech Co. Ltd. has partnered with Viora and will exclusively distribute Reaction™ in the growing Taiwanese medical aesthetic market. An accomplished and thriving company, Promed Biotech offers comprehensive and innovative solutions for surgical and aesthetic applications in Taiwan. “We are certain that this new venture will add further to Viora’s growing presence in the region,” commented Danny Erez, CEO of Viora. “We look forward to working with Promed Biotech.”
Viora’s Reaction™ is designed for non-invasive body contouring and skin tightening treatments and is the only device of its kind featuring the new-age CORE™ (Channeling Optimized RF Energy) technology combined with vacuum therapy. Reaction™ is currently available in over 50 countries and is endorsed by leading physicians and dermatologists worldwide.